Theranos initially claimed that Carreyrou’s reporting was faulty, and its legal counsel, David Boies, threatened the reporter with lawsuits. Ultimately, Carreyrou revealed that Theranos was misleading customers about its testing accuracy and methodology. After receiving the initial tip from a Missouri-based pathologist who’d doubted Holmes’s descriptions of her technology, Carreyrou’s investigation into the company resulted in a series of damning reports in The Wall Street Journal, starting with an October 2015 front-page story exposing the company’s dubious blood-testing practices. Over a tumultuous decade, she built a buzzed-about startup with big-name board members like George Shultz, raised over $700 million in financing from marquee investors like Carlos Slim and Betsy DeVos, and struck up partnerships with major corporations like Walgreens and Safeway.īut all the while, Holmes was scrambling to conceal Theranos’s shortcomings. Elizabeth Holmes, the founder, chairwoman, and CEO of Theranos, had a backstory that was irresistible: She’d started the company as a 19-year-old, working from within her Stanford dorm room. Theranos, which promised a needle-free way to conduct blood tests, was hailed as a potentially revolutionary company. When Wall Street Journal reporter John Carreyrou received a tip about Theranos, a Silicon Valley blood-testing startup with a pedigreed board of directors and heavyweight investor backing, he didn’t know it would lead to one of most audacious scams in startup history.
0 kommentar(er)
